Reduced PIN1 expression in neocortical and limbic brain regions in female Alzheimer's patients correlates with cognitive and neuropathological phenotypes.
Camila de ÁvilaCrystal SuazoJennifer NolzJ Nicholas CochranQi WangRamon VelazquezEric DammerBenjamin ReadheadDiego MastroeniPublished in: Neurobiology of aging (2024)
Women have a higher incidence of Alzheimer's disease (AD), even after adjusting for increased longevity. Thus, there is an urgent need to identify genes that underpin sex-associated risk of AD. PIN1 is a key regulator of the tau phosphorylation signaling pathway; however, potential differences in PIN1 expression, in males and females, are still unknown. We analyzed brain transcriptomic datasets focusing on sex differences in PIN1 mRNA levels in an aging and AD cohort, which revealed reduced PIN1 levels primarily within females. We validated this observation in an independent dataset (ROS/MAP), which also revealed that PIN1 is negatively correlated with multiregional neurofibrillary tangle density and global cognitive function in females only. Additional analysis revealed a decrease in PIN1 in subjects with mild cognitive impairment (MCI) compared with aged individuals, again driven predominantly by female subjects. Histochemical analysis of PIN1 in AD and control male and female neocortex revealed an overall decrease in axonal PIN1 protein levels in females. These findings emphasize the importance of considering sex differences in AD research.
Keyphrases
- mild cognitive impairment
- cognitive decline
- single cell
- signaling pathway
- poor prognosis
- end stage renal disease
- chronic kidney disease
- resting state
- newly diagnosed
- ejection fraction
- type diabetes
- spinal cord injury
- peritoneal dialysis
- dna damage
- white matter
- risk assessment
- pi k akt
- polycystic ovary syndrome
- patient reported outcomes
- adipose tissue
- reactive oxygen species
- insulin resistance
- oxidative stress
- brain injury
- human health
- pregnancy outcomes